The up-regulation of oxidative stress as a potential mechanism of novel MAO-B inhibitors for glioblastoma treatment
Gliomas are malignant brain tumors characterized by rapid spread and growth into neighboring tissues and graded I-IV by theWorld Health Organization. Glioblastoma is the fastest growing and most devastating IV glioma. The aim of this paper is to evaluate the biological effects of two potent and selective Monoamine Oxidase B (MAO-B) inhibitors, Cmp3 and Cmp5, in C6 glioma cells and in CTX/TNA2 astrocytes in terms of cell proliferation, apoptosis occurrence, inflammatory events and cell migration. These compounds decrease C6 glioma cells viability sparing normal astrocytes.